OPTIMIZERx is trading at $8.27 (+5.15%) after September 2, 2026 news that former Johnson & Johnson executive Troy Sarich joined its advisory board.
- The appointment adds nearly 30 years of healthcare, pharmaceutical commercialization, data, analytics, and AI experience.
- OptimizeRx said the role aims to accelerate innovation and strengthen life-sciences marketing technology.
- No volume data was available.